These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cardiovascular biology: a cholesterol tether. Staels B Nature; 2002 Jun; 417(6890):699-701. PubMed ID: 12066168 [No Abstract] [Full Text] [Related]
8. [Metabolism and clinical significance of lipoprotein Lp(a) (author's transl)]. Krempler F Acta Med Austriaca; 1980; 7(4-5):101-3. PubMed ID: 6454320 [TBL] [Abstract][Full Text] [Related]
9. [Value of apolipoprotein B determination in evaluation of atherogenic risk]. Messaoudia Y Arch Inst Pasteur Tunis; 1982 Mar; 59(1):217-20. PubMed ID: 7181567 [No Abstract] [Full Text] [Related]
10. [Hypertriglyceridemia and arteriosclerosis. Physiology and pathophysiology of chylomicron catabolism]. Beisiegel U; Ameis D; Will H; Greten H Internist (Berl); 1995 Apr; 36(4):357-61. PubMed ID: 7775084 [No Abstract] [Full Text] [Related]
11. [Cellular lipoprotein receptors in atherogenesis. II. Receptors for modified lipoproteins in macrophages]. Konarska R; Sznajd J Przegl Lek; 1986; 43(11):713-7. PubMed ID: 3575774 [No Abstract] [Full Text] [Related]
12. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL]. Breier C; Lisch HJ; Drexel H; Braunsteiner H Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113 [TBL] [Abstract][Full Text] [Related]
13. [Lipoproteins and lipoprotein receptors and their significance for the pathogenesis of arteriosclerosis]. Dresel HA; Schettler G Klin Wochenschr; 1983 Dec; 61(23):1171-9. PubMed ID: 6317940 [TBL] [Abstract][Full Text] [Related]
14. [Less well-known lipid "risk" factors of arteriosclerosis]. Pagnan A; Zanetti G; Guarini P; Dal Palú C G Clin Med; 1980 Aug; 61(8):593-600. PubMed ID: 7004983 [No Abstract] [Full Text] [Related]
15. Apolipoproteins, the lipid hypothesis and ischaemic heart disease. Avogaro P Przegl Lek; 1985; 42(8):602-6. PubMed ID: 4089215 [No Abstract] [Full Text] [Related]
16. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome]. Breier C; Lisch HJ; Drexel H; Braunsteiner H Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272 [TBL] [Abstract][Full Text] [Related]
17. Atherogenic lipid profile in elderly patients with ischaemic cerebrovascular disease. Cuchel M; Stott DJ; Gaw A; Vergani C; Packard CJ Lancet; 2000 Jul; 356(9227):401-2. PubMed ID: 10972378 [TBL] [Abstract][Full Text] [Related]
18. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke. Kostner GM; Marth E; Pfeiffer KH; Wege H Monogr Atheroscler; 1986; 14():119-23. PubMed ID: 3736549 [No Abstract] [Full Text] [Related]
19. Role of atherogenic lipoproteins in cytokine-mediated renovascular injury. Kirschenbaum MA; Pai R; Roh DD; Kamanna VS Miner Electrolyte Metab; 1996; 22(1-3):47-50. PubMed ID: 8676823 [TBL] [Abstract][Full Text] [Related]